Handa Pharmaceuticals Statistics
Total Valuation
TPEX:6620 has a market cap or net worth of TWD 11.72 billion. The enterprise value is 9.23 billion.
Market Cap | 11.72B |
Enterprise Value | 9.23B |
Important Dates
The last earnings date was Wednesday, April 2, 2025.
Earnings Date | Apr 2, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TPEX:6620 has 141.20 million shares outstanding. The number of shares has increased by 7.81% in one year.
Current Share Class | n/a |
Shares Outstanding | 141.20M |
Shares Change (YoY) | +7.81% |
Shares Change (QoQ) | +0.01% |
Owned by Insiders (%) | 3.86% |
Owned by Institutions (%) | 1.43% |
Float | 85.45M |
Valuation Ratios
The trailing PE ratio is 25.60 and the forward PE ratio is 5.19.
PE Ratio | 25.60 |
Forward PE | 5.19 |
PS Ratio | 11.90 |
PB Ratio | 4.04 |
P/TBV Ratio | 4.09 |
P/FCF Ratio | 15.73 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.06, with an EV/FCF ratio of 12.39.
EV / Earnings | 20.40 |
EV / Sales | 9.48 |
EV / EBITDA | 17.06 |
EV / EBIT | 17.38 |
EV / FCF | 12.39 |
Financial Position
The company has a current ratio of 17.75, with a Debt / Equity ratio of 0.01.
Current Ratio | 17.75 |
Quick Ratio | 17.71 |
Debt / Equity | 0.01 |
Debt / EBITDA | 0.07 |
Debt / FCF | 0.05 |
Interest Coverage | 2,294.41 |
Financial Efficiency
Return on equity (ROE) is 21.92% and return on invested capital (ROIC) is 15.71%.
Return on Equity (ROE) | 21.92% |
Return on Assets (ROA) | 14.66% |
Return on Invested Capital (ROIC) | 15.71% |
Return on Capital Employed (ROCE) | 17.57% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.43 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -51.32% in the last 52 weeks. The beta is 0.98, so TPEX:6620's price volatility has been similar to the market average.
Beta (5Y) | 0.98 |
52-Week Price Change | -51.32% |
50-Day Moving Average | 83.21 |
200-Day Moving Average | 79.27 |
Relative Strength Index (RSI) | 44.67 |
Average Volume (20 Days) | 429,271 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6620 had revenue of TWD 972.97 million and earned 452.32 million in profits. Earnings per share was 3.24.
Revenue | 972.97M |
Gross Profit | 971.68M |
Operating Income | 525.42M |
Pretax Income | 587.13M |
Net Income | 452.32M |
EBITDA | 529.31M |
EBIT | 525.42M |
Earnings Per Share (EPS) | 3.24 |
Balance Sheet
The company has 2.53 billion in cash and 36.89 million in debt, giving a net cash position of 2.49 billion or 17.65 per share.
Cash & Cash Equivalents | 2.53B |
Total Debt | 36.89M |
Net Cash | 2.49B |
Net Cash Per Share | 17.65 |
Equity (Book Value) | 2.90B |
Book Value Per Share | 20.56 |
Working Capital | 2.61B |
Cash Flow
In the last 12 months, operating cash flow was 746.52 million and capital expenditures -1.68 million, giving a free cash flow of 744.84 million.
Operating Cash Flow | 746.52M |
Capital Expenditures | -1.68M |
Free Cash Flow | 744.84M |
FCF Per Share | 5.28 |
Margins
Gross margin is 99.87%, with operating and profit margins of 54.00% and 46.49%.
Gross Margin | 99.87% |
Operating Margin | 54.00% |
Pretax Margin | 60.34% |
Profit Margin | 46.49% |
EBITDA Margin | 54.40% |
EBIT Margin | 54.00% |
FCF Margin | 76.55% |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 1.20%.
Dividend Per Share | 1.00 |
Dividend Yield | 1.20% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 1 |
Payout Ratio | 31.19% |
Buyback Yield | -7.81% |
Shareholder Yield | -6.61% |
Earnings Yield | 3.86% |
FCF Yield | 6.36% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
TPEX:6620 has an Altman Z-Score of 54.71.
Altman Z-Score | 54.71 |
Piotroski F-Score | n/a |